TScan Therapeutics Inc. (TCRX)
NASDAQ: TCRX
· Real-Time Price · USD
2.11
-0.07 (-3.21%)
At close: Oct 03, 2025, 3:59 PM
2.12
0.47%
After-hours: Oct 03, 2025, 04:58 PM EDT
13F Institute Ownership
Total Institutes of 75 in TScan Therapeutics reduced their positions with a decrease of 14 investors compared to the previous quarter. A reduction of 4.56M shares, as total invested capital declined by $3.88M with ownership percentage dropping from 29.89% to 26.36%.
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio | Filing Date |
|---|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 6.06% | 7.86M | +46.66% | 11.39M | 3.29% | Aug 14, 2025 |
| Bvf Inc/il | 4.03% | 5.23M | +6.88% | 7.58M | 0.27% | Aug 14, 2025 |
| Baker Bros. Advisors LP | 2.15% | 2.78M | +0.00% | 4.04M | 0.04% | Aug 14, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.